Researchers at the Eye Genetics Research Unit at Children's Medical Research Institute (CMRI) are the first in the world to ...
New research reveals that the loss of a single ion channel, TRPM1, is enough to produce persistent rhythmic oscillations in ...
Rhythmic electrical activity in the retina (known as pathological oscillations) has been observed in several eye diseases, including congenital stationary night blindness (CSNB) and retinitis ...
A brief period of blindness right after birth can have lasting effects on how the brain processes visual detail—but surprisingly, not on how it recognizes faces, objects, or words. The team studied ...
News Medical on MSN
TRPM1 loss drives rhythmic activity across retinal diseases
Rhythmic electrical activity in the retina (known as pathological oscillations) has been observed in several eye diseases, ...
The alliance extends a deal streak in genetic medicine for Lilly and hands the company rights to an experimental treatment ...
The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...
Money Talks News on MSN
Blind at 60. Vision restored at 61. Stanford research paves the way.
The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...
The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...
The gene therapy market for ocular rare diseases is expanding rapidly as breakthroughs in viral vectors (like AAV) and gene-editing tools enable one-time, disease-modifying treatments for previously ...
Eli Lilly and Co.’s stock hit an all-time high and almost reached $1,000 per share on Tuesday in the wake of several ...
Diabetes is one of the world’s fastest-growing health challenges – and its impact stretches across every life stage, from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results